Position in OGN
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$35
+$21 QoQ
Shares Held
6
+200.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bay Harbor Wealth Management, LLC holds $967,587 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,237 | $311,278 | |
| 2 | LLY |
ELI LILLY & Co
|
228 | $273,470 | |
| 3 | JNJ |
Johnson & Johnson
|
591 | $150,096 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,304 | $75,136 | |
| 5 | PFE |
Pfizer Inc
|
2,605 | $62,728 | |
| 6 | MRK |
Merck & Co., Inc.
|
319 | $40,991 | |
| 7 | AMGN |
Amgen Inc
|
72 | $26,072 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
174 | $21,983 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35 | 6 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $14 | 2 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $21 | 2 | Shares | Other | 2025-10-09 | |
| 2025-06-30 | $9 | 1 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $59 | 4 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $14 | 1 | Shares | Sole | 2025-01-27 | |
| 2021-06-30 | $423 | 14 | Shares | Sole | 2021-07-28 | |
| No filing history on record for this holder in this stock. | ||||||